Close Menu
Home › NIH Names Semifinalists in $20M Antibiotic Resistance Dx Competition

NIH Names Semifinalists in $20M Antibiotic Resistance Dx Competition

Mar 28, 2017
|
staff reporter

NEW YORK (GenomeWeb) – The National Institutes of Health yesterday announced the 10 semifinalists in the first phase of a $20 million competition to develop novel diagnostics for antibiotic resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  2. Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

  3. NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

  4. FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray

  5. Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.